## Abstract ## BACKGROUND Aberrant DNA methylation of the CpG islands for cancerβrelated genes is among the earliest and most frequent alterations in cancer and may be useful for diagnosing cancer or evaluating recurrent disease. ## METHODS In this study, a 3βdimensional (3βD), polyacrylamide ge
Promoter methylation of the RGC32 gene in nonsmall cell lung cancer
β Scribed by Dong Sun Kim; Ji Yun Lee; Su Man Lee; Jin Eun Choi; Sukki Cho; Jae Yong Park
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 249 KB
- Volume
- 117
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Many different targeted therapies with varying mechanisms of action have been added to standard firstβline chemotherapy doublets in an effort to improve survival of patients with advanced nonsmall cell lung cancer (NSCLC). Only 2 targeted therapiesβbevacizumab and cetuximabβhave been as
## Abstract ## BACKGROUND. Lung cancer is the leading cause of cancer deaths worldwide. The epigenetic inactivation of certain genes by aberrant promoter methylation plays an important role in the pathogenesis of lung cancer. In addition, DNA hypermethylation is an extremely promising cancer marke